share_log

Probo Medical Names Michael Asmer as Chairman and Greg Kopulos as CEO

Probo Medical Names Michael Asmer as Chairman and Greg Kopulos as CEO

Probo醫療公司任命邁克爾·阿斯梅爾爲主席,格雷格·科普洛斯爲首席執行官
PR Newswire ·  09/13 02:55

TAMPA, Fla., Sept. 12, 2024 /PRNewswire/ -- Probo Medical ("Probo"), a global diagnostic imaging solutions provider, has announced the appointment of Michael Asmer as Chairman of the Board and Greg Kopulos as Chief Executive Officer of Probo.

佛羅里達州坦帕,2024年9月12日 /PRNewswire/ — 全球診斷成像解決方案提供商Probo Medical(「Probo」)宣佈任命邁克爾·阿斯默爲董事會主席,格雷格·科普洛斯爲Probo首席執行官。

Michael Asmer was formerly Chief Executive Officer of Probo and, prior to Probo, was the founder and Chief Executive Officer of MedCorp, which was acquired by Probo in 2018. Prior to MedCorp, Asmer held various leadership roles at Physician Sales and Service (PSS), prior to its acquisition by McKesson, and also at Henry Schein. Asmer earned his Bachelor's degree from the University of South Carolina.

邁克爾·阿斯默曾任Probo首席執行官,在加入Probo之前,他是MedCorp的創始人兼首席執行官,該公司於2018年被Probo收購。在加入MedCorp之前,阿斯默曾在醫師銷售與服務(PSS)擔任過各種領導職務,之後曾在麥克森收購該公司,還曾在亨利·舍因擔任過各種領導職務。Asmer 在南卡羅來納大學獲得學士學位。

"I am tremendously proud of what our team has accomplished over the last five years at Probo and am also excited for what lies ahead," stated Asmer. "With the integration of recent acquisitions, Probo enters a new phase of growth where we can support our customers with a comprehensive offering of diagnostic imaging solutions."

阿斯默說:「我爲我們的團隊在過去五年中在 Probo 取得的成就感到非常自豪,也爲未來的工作感到興奮。」「隨着近期收購的整合,Probo進入了一個新的增長階段,我們可以爲客戶提供全面的診斷成像解決方案。」

Greg Kopulos joined Probo in 2024 from Chartis, a healthcare consulting firm where he was President of their Clinical Quality Solutions business. Prior to that, he spent 20 years at GE Healthcare where among other roles, he was Chief Operating Officer of Global Service, Chief Operating Officer of US & Canada as well as the Senior Vice President of Strategy. Kopulos earned his Masters of Business Administration from Marquette University and his Bachelor's degree from University of Wisconsin-Whitewater.

格雷格·科普洛斯於2024年從醫療保健諮詢公司Chartis加入Probo,他曾擔任該公司的臨床質量解決方案業務總裁。在此之前,他在GE Healthcare工作了20年,除其他職位外,他曾擔任全球服務首席運營官、美國和加拿大首席運營官以及戰略高級副總裁。Kopulos 擁有馬凱特大學的工商管理碩士學位和威斯康星大學懷特沃特分校的學士學位。

"Probo is well on its way to becoming a global leader in diagnostic imaging solutions. I am humbled and excited to build on the great work of Michael and the entire Probo team," remarked Kopulos. "With the continued investment in and integration of our prior acquisitions, Probo has never been better positioned to help our customers deliver quality care to their patients while providing needed cost savings."

「Probo 即將成爲診斷成像解決方案領域的全球領導者。能在邁克爾和整個 Probo 團隊的出色工作基礎上再接再厲,我感到既謙卑又興奮。」 科普洛斯說。「通過對我們先前收購的持續投資和整合,Probo比以往任何時候都更有能力幫助我們的客戶爲患者提供優質護理,同時節省所需的成本。」

Probo Medical is backed by Avista Healthcare Partners, a leading private equity firm focused exclusively on healthcare with over $8 billion invested in more than 45 growth-oriented healthcare businesses globally.

Probo Medical由Avista Healthcare Partners提供支持,Avista Healthcare Partners是一家專注於醫療保健的領先私募股權公司,在全球超過45家以增長爲導向的醫療保健企業投資了超過

About Probo Medical
Probo Medical is a global diversified solutions provider of diagnostic imaging products and services, including equipment sales, service, rental, repair and installation. For more information about Probo Medical, visit .

關於 Probo Medical
Probo Medical是診斷成像產品和服務的全球多元化解決方案提供商,包括設備銷售、服務、租賃、維修和安裝。有關 Probo Medical 的更多信息,請訪問。

Contacts

聯繫人

For Probo Medical:
Contact: Adam Walter, Probo Medical
Email: [email protected]

對於 Probo Medical:
聯繫人:Probo Medical 的亞當·沃爾特
電子郵件:[電子郵件保護]

For Avista Healthcare Partners:
Daniel Yunger / William Halliday
Kekst CNC
[email protected] / [email protected]

對於 Avista 醫療保健合作伙伴:
丹尼爾·揚格/威廉·哈利迪
Kekst CNC
[電子郵件保護]/[電子郵件保護]

SOURCE Probo Medical

來源 Probo Medical

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想在 PRNEWSWIRE.COM 上刊登貴公司的新聞嗎?

440k+
440k+

Newsrooms &
新聞編輯室和

Influencers
有影響力的人
9k+
9k+

Digital Media
數字媒體

Outlets
網點
270k+
270k+

Journalists
記者

Opted In
選擇加入
GET STARTED
開始吧

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論